Creative Touch Permanent Makeup and Aesthetics

Transepidermal water loss (TEWL) is the passive diffusion of water vapour through the stratum corneum – the primary quantitative measure of skin barrier competency, expressed in g·m⁻²·h⁻¹. It is both a consequence and a driver of barrier disruption: elevated TEWL increases permeability to allergens and irritants, suppresses filaggrin expression, degrades ceramide content, and accelerates desquamation – each step further elevating TEWL. Reference values vary by site (4–8 g·m⁻²·h⁻¹ at the forearm; significantly higher at the face and lip vermilion); clinically significant elevation is documented in AD, psoriasis, rosacea, and acne. Petrolatum reduces TEWL acutely by physical occlusion; ceramide and pseudo-ceramide formulations restore barrier structure over days to weeks. TEWL measurement at consultation provides objective baseline data that visual assessment alone cannot.

Water moves through the stratum corneum by passive diffusion along a concentration gradient – from the water-rich viable epidermis below to the relatively dry environment above. Under normal conditions, this movement is controlled and modest: the lamellar lipid bilayers of the stratum corneum, the corneocyte protein envelope, and the natural moisturising factor (NMF) within corneocytes together form a regulated permeability barrier that limits water loss to physiological rates. When any component of this barrier is disrupted – whether by lipid depletion, corneocyte scaffold failure, tight junction dysfunction, or inflammatory degradation – TEWL rises in proportion to the degree of disruption. It is this proportionality that makes TEWL clinically useful: it is not a binary indicator of barrier presence or absence but a continuous variable that tracks barrier integrity across a measurable range.

Measurement: Methods and Instruments

TEWL is expressed in grams of water per square metre per hour (g·m⁻²·h⁻¹) and is measured non-invasively using evaporimetry – the detection of water vapour flux at the skin surface. Three instrument types are in clinical and research use, each with distinct characteristics: ^[6]

• Open-chamber devices (Tewameter TM 300, TM Hex, DermaLab): The most widely used class in research and clinical dermatology. A cylindrical probe open at both ends is held against the skin surface; humidity and temperature sensors within the chamber measure the water vapour gradient, from which flux is calculated using Fick’s law of diffusion. Measurements are sensitive to ambient air movement and require a controlled environment. The Tewameter TM Hex (2023) uses a matrix of 30 sensors rather than the two-sensor arrangement used since Nilsson’s original 1977 design, producing a coefficient of variance of 11% versus 19% for the TM 300 – a significant improvement in measurement reproducibility. ^[3]

• Closed-chamber devices (Vapometer): A sealed chamber traps a small air volume against the skin; the rate of humidity rise within the closed volume is used to calculate TEWL. Less sensitive to ambient air movement but requires careful sealing and produces slightly different absolute values than open-chamber devices, limiting direct cross-study comparison. ^[4]

• Condenser-chamber devices (AquaFlux): Water vapour condenses onto a cooled surface within the probe; the condensate mass is measured. This approach is less affected by ambient humidity fluctuations and is considered particularly accurate under conditions of high ambient humidity.

Reference TEWL values vary significantly by anatomical site, reflecting the structural differences in barrier thickness and lipid composition across body regions. Typical healthy adult values range from approximately 4–8 g·m⁻²·h⁻¹ at the forearm (the standard reference site in research) to 10–15 g·m⁻²·h⁻¹ on the face, with the lip vermilion registering the highest values of any facial site – approximately three times the cheek value – reflecting its structurally thinner barrier. ^[5]

TEWL in Inflammatory Skin Conditions

TEWL elevation has been quantified across the principal inflammatory skin conditions of aesthetics practice, providing objective reference points for barrier impairment severity:

Atopic dermatitis (AD): TEWL is consistently and substantially elevated in AD, both at lesional skin and – critically – at clinically uninvolved skin in AD patients, demonstrating that barrier dysfunction in AD is a systemic feature of the condition rather than localised to visible lesions. A TEWL threshold above 23.19 g·m⁻²·h⁻¹ at clinically assessed sites indicated moderate-to-severe AD with 73.5% sensitivity in a clinical cohort. ^[7] TEWL in active AD lesions may reach 30–60 g·m⁻²·h⁻¹ – five to ten times the normal forearm reference value.

Psoriasis: TEWL is elevated at psoriatic plaques relative to healthy controls, with a threshold above 13.85 g·m⁻²·h⁻¹ indicating moderate-to-severe psoriasis (PASI ≥ 7) with 81.8% sensitivity and 50.8% specificity – establishing TEWL as a useful objective complement to PASI scoring for treatment decisions. ^[7] Paradoxically, TEWL at psoriatic plaques may be lower than at uninvolved psoriatic skin in some studies, reflecting the hyperkeratotic scale layer that provides partial physical occlusion above the disrupted underlying epidermis.

Rosacea: Elevated TEWL in rosacea reflects the combination of reduced barrier lipid content, upregulated aquaporin-3 (AQP3) expression driven by the cathelicidin LL-37 – a key rosacea inflammatory mediator – and the cytokine-mediated tight junction disruption driven by TLR-2 overexpression. ^[2] This places barrier support alongside anti-inflammatory management as a dual clinical target in rosacea care.

Acne vulgaris: TEWL elevation in acne reflects both the direct barrier disruption from inflammatory lesions and the broader sebaceous gland dysfunction that alters the surface lipid film. Barrier impairment in acne is clinically relevant to treatment tolerance – acne-prone skin with elevated TEWL is more sensitive to the barrier-disrupting effects of retinoids, benzoyl peroxide, and low-pH actives, and the therapeutic window for these agents is narrower in clients with measurably compromised baseline barrier function.

TEWL as a Bidirectional Driver

TEWL elevation is both a consequence of barrier disruption and an active driver of further disruption – a self-reinforcing cycle with direct clinical relevance. When TEWL rises, the stratum corneum hydration decreases; dry corneocytes shrink and the tight lateral packing of the lipid lamellar structure loosens, increasing permeability further. Reduced stratum corneum hydration also activates kallikrein serine proteases, which degrade corneodesmosin and accelerate desquamation, thinning the barrier further. In inflammatory conditions, elevated TEWL increases barrier permeability to allergens, irritants, and microbial products – which activate TLR-mediated innate immune responses, drive cytokine production (particularly IL-4, IL-13, and TSLP in AD), suppress filaggrin expression, and degrade the ceramide profile of the lamellar bodies – each step of which further elevates TEWL. ^[2]

This bidirectionality is the mechanistic basis for the clinical principle that barrier restoration is foundational to the management of every inflammatory skin condition, not a cosmetic adjunct. Treating the inflammatory component without simultaneously reducing TEWL leaves the cycle of barrier disruption and allergen/irritant penetration active.

Treatment Effects on TEWL

The evidence for TEWL reduction by topical interventions is broadly consistent but more nuanced than often presented:

• Petrolatum (petroleum jelly): The most effective occlusive for acute TEWL reduction, reducing evaporative loss by up to 99% at the treated surface through physical occlusion. Does not restore barrier structure – seals the surface without supplying the lipid components the barrier needs to rebuild.

• Ceramide-containing moisturisers: Widely recommended for barrier repair. Clinical trial evidence shows significant improvement in AD severity scores (SCORAD) with ceramide moisturisers, but a meta-analysis of TEWL outcomes found no statistically significant reduction in TEWL compared to other moisturisers (mean difference −3.56, 95% CI −8.63 to 1.52, p = 0.17) – suggesting ceramide moisturisers improve clinical outcomes through mechanisms beyond TEWL reduction alone, or that TEWL measurement variability obscures real effects. ^[8]

• Pseudo-ceramide formulations: A 2024 RCT found significant TEWL reduction with pseudo-ceramide-containing moisturiser after four weeks, with TEWL changes negatively correlated with pseudo-ceramide absorption into the stratum corneum – directly linking lipid replenishment to barrier restoration. ^[1]

• Ceramide + urea combinations: Evidence suggests faster TEWL repair (within 7 days) compared to lanolin or petrolatum alone (which require 14+ days), supporting combination formulations over single-ingredient approaches for speed of barrier restoration. ijshr